Clinical and Diagnostic Laboratory Immunology, May 2002, p. 738, Vol. 9, No. 3
1071-412X/02/$04.00+0 DOI:
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
| ERRATUM |
Department of Pediatrics, Medical University of Lübeck, Lübeck, Germany
Volume 9, no. 2, p. 295-298, 2002. Page 297, column 1: line 7 from bottom and below should read as follows. "The greatest mean difference was seen for IL-8, with a 44.9% higher amount of IL-8 positive monocytes (95% CI, 33.7% to 56%; P < 0.0001) compared to the purified antibody-blocking control, followed by a 29% higher amount of IL-6-positive cells (95% CI, 16.7% to 41.3%; P < 0.0001), a 19.4% higher amount of IFN-
-positive cells (95% CI, 14.3% to 24.6%; P < 0.0001), and a 14.5% higher amount of IL-2 positive cells (95% CI, 10.7% to 18.2%; P < 0.0001)."
Page 297, column 2: line 10 from bottom and below should read as follows. " ... then the number of IL-6 positive monocytes was 69.3% higher (95% CI, 37.8% to 100.7%; P < 0.0001) than that obtained with the purified antibody-blocking control, followed by a 26.9% higher amount of IFN-
-positive lymphocytes (95% CI, 20.9% to 32.8%; P < 0.0001) and a 18.8% higher amount of IL-2-positive lymphocytes (95% CI, 13.7% to 24%; P < 0.0001). In the determination of IL-8, 6 values were below and 14 values above those of the purified antibody-blocking control (18.7%; 95% CI, 14.5% to 22.9%; P < 0.05)."
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |